Challenging Cases in Skin of Color Patients
This year at the 17th Annual Dermatology, Aesthetic & Surgical Conference (ODAC), Dr Amy McMichael presented the audience with new pearls of advice on how to approach and diagnose complex medical dermatology cases in patients with skin of color. During her session, she addressed the important need for providers to be able to recognize disease in patients of all races. The majority of the glob …
This year at the 17th Annual Dermatology, Aesthetic & Surgical Conference (ODAC), Dr Amy McMichael presented the audience with new pearls of advice on how to approach and diagnose complex medical dermatology cases in patients with skin of color. During her session, she addressed the important need for providers to be able to recognize disease in patients of all races. The majority of the glob … Continue reading "Challenging Cases in Skin of Color Patients"
Sprinkled with many clinical pearls, Dr. Candrice Heath gave us an informative, case-based lecture at the 2021 Skin of Color Update: “Skin Conditions Disproportionately Affecting Pediatric & Adolescent Patients with Skin of Color.” Dr. Heath is an Assistant Professor and Director of Pediatric Dermatology at Lewis Katz School of Medicine at Temple University and is active on social media @D … 
With the American Academy of Dermatology Annual Meeting (often referred to as just "AAD") in Denver at the end of March, excitement is in the air! Without a doubt the Super Bowl of dermatology conferences, AAD can be an accelerating and even career-shaping experience, but the first time it can be equally overwhelming. Whether you are a medical student exploring dermatology or a first-year resident … 
Transitioning from a third-year residency into the professional workforce is a major milestone that requires a strategic approach. Unlike fellowship tracks, which offer an additional year of buffer, going straight into the workforce demands immediate and thoughtful preparation. By following these core principles, you can navigate the complexities of the job market and secure a position that aligns … 
Tacrolimus and Pimecrolimus are both calcineurin inhibitors FDA-approved for atopic dermatitis. However, their topical use offers steroid-sparing benefits for a wide variety of other inflammatory dermatologic conditions. Tacrolimus was discovered in 1984 from the soil bacterium Streptomyces tsukubaensis and was originally FDA approved in 1994 as a systemic immunosuppressant for organ transplanta …